RAPT Overview
Upcoming Projects (RAPT)
-
Discussing the treatment landscape for peanut allergies, including RAPT's long acting ozureprubart, OIT, Xolair and SLIT, as well as DBVT's Viaskin Peanut studies.
Tickers: RAPT, NVS, DBVT
Scheduled For: Dec 04, 2025 at 09:00 AM EST
Executed Projects (RAPT)
-
Delving into RAPT Therapeutics phase 2 trial data of RPT904 (JYB1904) in chronic spontaneous urticaria
Ticker: RAPT
Executed On: Nov 06, 2025 at 02:00 PM EST
Upcoming & Overdue Catalysts (RAPT)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (RAPT)
-
RAPT Therapeutics (RAPT) Reports Initial Data from Ongoing Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications
Ticker: RAPT
Occurred on: Nov 16, 2020
Strategic Initiatives (RAPT)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
